GlaxoSmithKline focus of UK fraud inquiry
- GSK is being investigated for alleged fraudulent marketing activities in the United Kingdom (UK)
- The company also is the focus of a corruption and bribery inquiry in China
- GSK has issued a statement reaffirming its commitment to operating based on "highest ethical standards"
This investigation comes on top of a long-simmering investigation of GSK, which has been accused of bribing doctors in China. There are also additional claims of bribery in Poland, Iraq, Jordan and Lebanon.
GSK has started to overhaul its approach to sales and marketing, and has issued a statement reaffirming its commitment to operating based on the "highest ethical standards."
- Pharma Times UPDATED: UK launches criminal investigation into GSK